GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

BioMarin Pharmaceutical falls 3.10% in Tuesday's session

Published by Global Banking & Finance Review

Posted on November 3, 2026

1 min read
Add as preferred source on Google
BMRN 55.66 -3.10% last traded price, 3 Nov 2026
Previous close
57.44
Market cap
—

The figures in this article were checked against this snapshot before publication.

BioMarin Pharmaceutical's shares in the United States health care sector last traded at 55.66 USD, 3.10% below their previous close of 57.44 USD on 3 November 2026.

Last traded price55.66 USD
Previous close57.44 USD
Change from the previous close-3.10%

Prices of BioMarin Pharmaceutical (BMRN), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 3 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 2 November 2026. We report a stock the day it ends a session 2% or more away from its previous close, where the previous session's trading was worth at least US$5 million. How we compile these reports.

BioMarin Pharmaceutical — daily BMRN Delayed

Related Articles

More from Markets

Explore more articles in the Markets category